2022
DOI: 10.1016/j.carbpol.2021.118923
|View full text |Cite
|
Sign up to set email alerts
|

Biomedical applications of polysaccharide nanoparticles for chronic inflammatory disorders: Focus on rheumatoid arthritis, diabetes and organ fibrosis

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(17 citation statements)
references
References 227 publications
0
17
0
Order By: Relevance
“…Rheumatoid arthritis (RA) is a chronic inflammatory disease that affects the joints. Polysaccharides and polysaccharides-based nanoparticles have been widely researched in RA treatment [ 194 ]. Dendrobium huoshanense stem polysaccharide treats RA by inhibiting inflammatory signaling pathways [ 195 ].…”
Section: Polysaccharide Based Drug Delivery For Diseases Therapeuticsmentioning
confidence: 99%
“…Rheumatoid arthritis (RA) is a chronic inflammatory disease that affects the joints. Polysaccharides and polysaccharides-based nanoparticles have been widely researched in RA treatment [ 194 ]. Dendrobium huoshanense stem polysaccharide treats RA by inhibiting inflammatory signaling pathways [ 195 ].…”
Section: Polysaccharide Based Drug Delivery For Diseases Therapeuticsmentioning
confidence: 99%
“…Peptides and polysaccharides may be degraded in the body using enzymes and the breakdown rate can be controlled to get the desired release profile. Dextran, gelatin, poly(L-lysine), chitosan, and alginate are among them [21,54]. The delivery channels and disease targets may all benefit from synthetic polymers that have desired features such as hydrophobicity and degradation profile.…”
Section: Slnsmentioning
confidence: 99%
“…Polysaccharides are natural biopolymers that play different roles in microorganisms, plants and animals [ 12 ]. They consist of long monomers of similar type or combinations of other monomer chains [ 13 ]. Natural polysaccharides are recognized as safe for targeting delivery due to their superior characteristics, including non-toxicity and non-reactivity, easy availability on a large scale, relative cheapness, significant biocompatibility and extraordinary biodegradability ( Figure 1 ) [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%